How physicians use array comparative genomic hybridization results to guide patient management in children with...

Area of Science:

• Genetics
• Pediatrics
• Medical Diagnostics

Background:

• Array comparative genomic hybridization (ACGH) is an increasingly utilized clinical tool for diagnosing developmental delay.
• Limited data exist on how healthcare providers integrate ACGH findings into patient care.
• This study addresses the clinical utility of ACGH by examining its impact on management decisions.

Purpose of the Study:

• To evaluate how physicians utilize positive array comparative genomic hybridization results in managing pediatric patients.
• To assess the impact of ACGH findings on clinical decision-making and patient care pathways.

Main Methods:

• A pilot study surveyed 14 physicians involved in the care of 48 pediatric patients.
• Patients included in the survey had copy number variations (CNVs) detected via microarray technology.
• Data collection focused on management changes implemented post-ACGH result disclosure.

Main Results:

• Over 70% of patients (34/48) experienced 65 management changes following ACGH results.
• Common changes included providing recurrence risk (35%), avoiding further testing (35%), and enhancing service access (25%).
• Physicians altered medical management in 27% of cases, involving specialist referrals or medical screenings.

Conclusions:

• Physicians reported significant changes in patient management based on ACGH results, comparable to conventional cytogenetics.
• The findings indicate that ACGH is actively influencing the management of children diagnosed with developmental delay in clinical practice.
• This study highlights the practical impact of ACGH in guiding therapeutic and diagnostic strategies for pediatric developmental disorders.